Wednesday, November 11, 2026

Latest:

VA trial to study effects of GLP-1s for alcohol use disorder among veterans
New treatment reduces heart scarring and abnormal heart rhythms, offering a possibility for future therapies
Testosterone: More than sex, muscle and masculinity
Glioblastoma fights back and often defeats the brain’s defenses against tumor growth
Can you train your lungs?

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

semaglutide

VA trial to study effects of GLP-1s for alcohol use disorder among veterans

November 11, 2026 alcohol, alcohol use disorer, GLP-1, Michael E. DeBakey Veterans Affairs Medical Center, semaglutide, veteran, veteran care, Veterans Day

Dr. Chris Verrico discusses how GLP-1s show promise to treat alcohol use disorder among veterans and hopeful outcomes for the study.

Policywise

Why do so few eligible patients undergo bariatric surgery?

October 4, 2024 Bariatric surgery, Equity, Obesity, semaglutide, Weight Loss

Bariatric surgery is an effective and durable treatment for individuals with obesity and its related health conditions. However, only a tiny minority of eligible patients

From the Labs: Brown Fat